Drug Profile
Sodium valproate - Kowa
Alternative Names: K 828; K-828-AB; K-828-SP; Valproate sodiumLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Kowa
- Class Antidementias; Antiepileptic drugs; Small molecules
- Mechanism of Action 4-aminobutyrate transaminase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Dementia; Spinal muscular atrophy
Most Recent Events
- 24 Sep 2021 Discontinued - Phase-III for Spinal muscular atrophy in Japan (PO)
- 30 Sep 2018 Kowa Pharmaceuticals completes phase III trial in Spinal muscular atrophy in Japan (In children) (JapicCTI-163450)
- 12 Oct 2016 Chemical structure information added